Document Detail

Serum calcium during chemotherapy for active pulmonary tuberculosis.
MedLine Citation:
PMID:  6884447     Owner:  NLM     Status:  MEDLINE    
Serum calcium was prospectively studied in 50 consecutive patients with active pulmonary tuberculosis. Twenty-four of them (48%) developed hypercalcaemia during an observation period of at least 8 weeks. Maximal increase in serum calcium (corrected for serum albumin) occurred three weeks after initiation of treatment, by which time 28% of the patients were hypercalcaemic. The increase in serum calcium was followed by a spontaneous remission. Only two patients developed symptoms related to hypercalcaemia, which promptly responded to steroid administration. No patient received vitamin D supplements before or during the study. No correlation could be found between hypercalcaemia and either the presence of acid-fast bacilli in the sputum or the season of the year. There was a trend for higher serum calcium values in the patients with the more severe radiographic changes on admission. Hypercalcaemia in patients with pulmonary tuberculosis seems to be triggered by chemotherapy. However, the mechanism(s) by which anti-tuberculosis treatment affects calcium metabolism remains uncertain.
M P Kitrou; A Phytou-Pallikari; S E Tzannes; K Virvidakis; T D Mountokalakis
Related Documents :
7468037 - Clinical effects of parathyroid surgery in normocalcaemic patients with recurrent renal...
15366747 - Long-term follow-up of patients with elevated pth levels following successful explorati...
21253827 - Growth, final height and endocrine sequelae in a uk population of patients with hurler ...
18311537 - Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scin...
15845217 - Clinical and histological features of multiple meningiomas compared with solitary menin...
22895237 - Prevalence of iron overload in pediatric oncology patients after blood transfusion.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of respiratory diseases     Volume:  64     ISSN:  0106-4339     ISO Abbreviation:  Eur J Respir Dis     Publication Date:  1983 Jul 
Date Detail:
Created Date:  1983-10-21     Completed Date:  1983-10-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8006891     Medline TA:  Eur J Respir Dis     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  347-54     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antitubercular Agents / adverse effects,  therapeutic use
Drug Therapy, Combination
Hypercalcemia / chemically induced*
Middle Aged
Prospective Studies
Tuberculosis, Pulmonary / drug therapy*,  metabolism
Reg. No./Substance:
0/Antitubercular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nebulized fenoterol in severe asthma: determinants of the dose response.
Next Document:  Differential diagnosis of viral, mycoplasmal and bacteraemic pneumococcal pneumonias on admission to...